Archive
The Daily Beat
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, hopes to start testing a DNA vaccine by September.
We continue to chat with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who hopes to start testing a DNA vaccine by September.
We continue to talk with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who hopes to start testing a DNA Zika vaccine by September.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, hopes to start testing a DNA vaccine by September.
You've just tuned in to The Daily Beat! This week on the Daily Beat: We chat with Thomas Rothstein, a biologist at the Feinstein Institute for Medical Research, to learn about his work with Cuban doctors for the lung cancer vaccine called Racotumomab. Today on the Daily Beat, Firday March 25, 2016: We continue to speak with Thomas Rothstein, a biologist at the Feinstein Institute for Medical Research, has for six years worked with the Center for Molecular Immunology on another vaccine to treat lung cancer called Racotumomab, with an entirely different mechanism. (It messes with a particular lipid found in tumor cell membranes.) “Investigators from around the world are trying to crack the nut of cancer,” Rothstein says in an interview with Wired.com. “The Cubans are thinking in ways that are novel and clever.” 00:00 The Daily Beat Intro 01:15 The Daily Beat pt. 1 - Thomas Rothstein 04:30 The Daily Beat pt. 2 - Global Collaboration 09:00 The Daily Beat pt. 3 - Working across the world for a cure 11:22 The Daily Beat Outro 12:18 Gaunt - Kiasmos 17:32 Finish
We learn what how the Cuban embargo impacts the ability for researchers to collaborate on innovative treatments.
We learn about the Cuban process in researching and creating new, low-cost drugs for its citizens.
We continue to speak with Thomas Rothstein, a biologist at the Feinstein Institute for Medical Research, working for six years for a revolutionary vaccine to treat lung cancer.
We chat with Thomas Rothstein, a biologist at the Feinstein Institute for Medical Research, about his work with Cuban doctors for the lung cancer vaccine called Racotumomab.
Dr. Charles Mueller, clinical associate professor of nutrition at NYU Steinhardt, discusses the movement toward food with less additives.
Continuing the conversation on how there have been no conclusive long-term medical effects on consuming MSG.
Learning about processed foods that tend to have long lists of ingredients that add flavor, color and texture, along with preservatives to extend shelf life.
Today, we'll take a close look at the most common food additives and preservatives you should know about.
Charles Mueller, clinical associate professor of nutrition at NYU Steinhardt, will discuss the health effects of the common additives.
We continue to learn about Dr. Unguru and his colleagues' framework to deal with these shortages in pediatric oncology
We continue to learn that the drug shortages don't end at cancer treatment agents but also for milder diseases and illnesses too.
We continue the conversation and learn about the ethical framework being build out to manage the shortage, however finding a solution is an ongoing battle.
We continue the conversation with Dr. Yoram Unguru about the bioethical difficulties in treating patients with pediatric cancer during this drug shortage epidemic.
We speak with Dr. Yoram Unguru, a pediatric oncologist at Children's Hospital at Sinai and professor at the Johns Hopkins Berman Institute of Bioethics.
We speak with the founder and leader of the Oneironauticum, an international dream group that explores the use of oneirogens that promote vivid dreaming.
We learn how dreamwork in a workshop program can have practical applications to your waking life.
We learn the difference between liminal and lucid dreaming and how they can both feed our creative selves.
Part 2 with Jennifer Dumpert talking about the group dreaming workshops she leads that promote untapped ideas.

recommendations